CT-Based Radiomics Deep-Learning Model Predicts Lymph Node Metastasis in Pancreatic Cancer
While rare, nonfunctional pancreatic neuroendocrine tumors are primarily treated through surgery. The presence or absence of lymph node metastasis considerably inﬂuences the selection of surgical and other treatment approaches. Particularly controversial is the necessity of surgery for tumors smaller than 2 cm as current clinical guidelines provide no clear consensus. Existing methods for preoperative diagnosis of lymph node metastasis are inadequate.
To address this challenge, the Tsukuba team has created a predictive model by integrating radiomics features extracted from CT and MRI images using artiﬁcial intelligence deep-learning techniques. This model has demonstrated an 89% success rate in predicting lymph node metastasis, a rate that rises to 91% when the model is validated with data from an external hospital. Furthermore, the performance of the model remains consistent, irrespective of the tumor size being larger or smaller than 2 cm.
In conclusion, the model can help predict lymph node metastasis. Moreover, the model equips surgeons with a crucial tool for selecting the most appropriate surgical procedures and treatment strategies, potentially transforming patient outcomes in the challenging medical ﬁeld.
Call for Papers
ARO is seeking original case reports, research articles, and review articles on innovative topics offering practical applications in radiation oncology. Manuscripts undergo a double-blinded external peer review process, and there is no submission fee.
- First Clinical Results Published for 177Lu-rhPSMA-10.1 in mCRPC Trial
- Opaganib Shown to Protect Against Radiation-Induced Lung Inflammation
- Fusion Licenses Actinium-Based PSMA Targeted Radiotherapy From Heidelberg University and Euratom
- Future of Theranostics in Neurooncology Looks Promising With Recent Advancements
- First Cellular Therapy for Unresectable or Metastatic Melanoma Receives FDA Approval